Modified SALT Score for Alopecia Areata

Kasr El Aini Hospital20 enrolled

Overview

Patchy Alopecia areata was treated by intralesional steroids for 3 months and was evaluated by percentage of involvement, mSALT score and dermoscopy.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

DOUBLE

Enrollment

Conditions

Alopecia Areata

Interventions

Triamcinolone AcetonideDRUG

intralesional injection of triamcinolone acetonide every 2 weeks for 6 sessions

salineOTHER

intralesional injection of saline

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * localized scalp AA ( 2 patches and ≤50% scalp involvement , duration more than 6 months) • patients who did not receive any medication for at least 2 months before starting the study and those who agreed to join the study and signed written consent. Exclusion Criteria: * • pregnant, and lactating females * Alopecia totalis or universalis or ophiasis or cicatritial alopecia * Usage of systemic treatment of alopecia areata 2 months prior to the study. * Any scalp lesion within the treated area * Bleeding diathesis, severe anemia or platelet disorders * Medical conditions such as autoimmune diseases.

Locations (1)

Kasr El Ainy university hospital, Faulty of medicine,Cairo university

Cairo, Egypt

RECRUITING

Outcomes

Primary Outcomes

Percentage involvement

Degree of severity expressed as a percentage

Time frame: 6months to 1 year

Modified Severity of Alopecia Tool (mSALT) score

New Score calculating severity (hair density) and area as a number minimum value is 0 and maximum value is 105 the higher the number of the score the worse the affection

Time frame: 6 months to 1 year

Central Contacts

Rana Hilal, MD

CONTACT

1001488869 rana.hilal@kasralainy.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.